The US Food and Drug Administration (FDA) has approved Warner Chilcott's new oral contraceptive MINASTRIN 24 FE.
MINASTRIN 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) is indicated for use by females of reproductive age for the prevention of pregnancy.
A third party manufactures MINASTRIN 24 FE for Warner Chilcott.
Specialty pharmaceutical company Warner Chilcott is focused on the women's healthcare, gastroenterology, urology and dermatology areas of the branded pharmaceuticals market, mainly in North America.
Source:
http://regulatoryaffairs.pharmaceutical-business-review.com/news/fda-approves-warner-chilcott-oral-contraceptive-medication-230413